Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Pancreatic Cancer|Mesothelioma|Ovarian Cancer|Non-Small Cell Lung Cancer |
| Start Date: | May 1, 2006 |
| Phase: | Phase I |
| Status: | Completed |
| NCT ID: | NCT00325494 |
| Study Type: | Interventional |
| Intervention: | Drug: MORAb-009 |
| Study Design: | Allocation: Non-Randomized|Control: Uncontrolled|Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Morphotek |
| Ages: | Adult|Senior |
| Enrollment: | 21 |
| Funded By: | Industry |
| First Received: | May 11, 2006 |
| End Date: | September 1, 2008 |
| Last Updated: | December 2, 2008 |
| Last Verified: | December 1, 2008 |